Absorbable Heart Stent Market Players, Focuses on SWOT analysis, Synopsis, Development Plans 2022 to 2030

The absorbable heart stent market is expected to reach USD 348.47 Million by 2030 at 13.20% CAGR during the forecast period 2022-2030.

Absorbable Heart Stent Market Highlights

In 2015, according to WHO reports, globally, the prevalence of cardiac disease in adults aged 18 and above was around 24.1% in men and 20.1% in women largely from low- and middle-income countries. Increasing unhealthy habits, lack of physical exercise and increasing prevalence of cardiac diseases contributed growth to the market. According to American college of cardiology, absorbable heart stent will replace the conventional metal stents in coming years. This is due to number of advantages of using absorbable heart stents. Most bioresorbable stents are made of polylactic acid. It is a naturally dissolvable material used in medical implants. Demand for absorbable heart stents is increasing due to advancement in technology of developing heart stents and increase in number of cardiac surgeries.

Absorbable Heart Stent Market Overview and Analysis by material, application, end-user  and region - forecast till 2030. The absorbable heart stent market is expected to reach USD 348.47 Million by 2030 at 13.20% CAGR during the forecast period 2022-2030.

On the other hand, there are few hurdles in the growth of this market. One of the biggest players in absorbable stent market, Abbott Vascular, has stopped manufacturing of its interventional cardiology product ABSORB GT. The company has terminated sales and operations related to this product in all the countries across the world due to the increased heart attack incidences with the use of its product. This major development may result in thwarting the growth of the market soon. However, market may regain its growth if the company resolves the issue in time and come up with better product in the market.


Global absorbable heart stent market has been segmented based on material used for bio absorbable stents which includes metal and polymer. The end users are hospitals, cardiac canters, research institutes and other users.

Regional Analysis

The Absorbable Heart Stent Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas dominates the Absorbable Heart Stent Market due to high healthcare expenditures, a well-developed healthcare sector, and increasing prevalence of the coronary artery diseases. Moreover, the presence of developed economies like the U.S. and Canada facilitates the market growth during the forecast period.  Europe stands second in the Absorbable Heart Stent Market and is estimated to be followed by Asia Pacific. Huge patient population, increasing research and development expenses, and increasing awareness are the major drives the market growth within Europe. Asia Pacific region is estimated to be the fastest growing for the Global Absorbable Heart Stent Market. This can be attributed to the presence of developing economies like India and China, a developing healthcare sector, growing healthcare industries within the region. However, the Middle East & Africa is estimated to hold the least market share of the market owing to the presence poor economies and stringent government policies within the African region.

Market Players:

Absorbable heart stent market players are Abbott Laboratories (U.S.), Biotronik (Germany), Arterial Remodeling Technologies SA (France), Amaranth Medical Inc. (U.S.), Kyoto Medical Planning Co. Ltd. (Japan), Elixir Medical Corporation (U.S.), and Reva Medical Inc. (U.S.).

Abbott Laboratories is an American healthcare company operating in more than 150 countries across the world. ABSORB GT is a bioresorbable vascular scaffold system manufactured by the company. In April 2016, the company entered into an agreement of acquiring St. Jude Medical thus strengthening its position in the market for heart stents and other vascular devices.

Biotronik is a multinational biotechnology company. Orsiro is a drug eluting stent and PK papyrus is a covered stent manufactured by the company. The company won Cardiostim Innovation Award for Best Practice Improvement in the year 2016.
About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com